Literature DB >> 21664948

Ubiquitin-independent proteasomal degradation during oncogenic viral infections.

Jiwon Hwang1, Laura Winkler, Robert F Kalejta.   

Abstract

Most eukaryotic proteins destined for imminent destruction are first tagged with a chain of ubiquitin molecules and are subsequently dismantled by the proteasome. Ubiquitin-independent degradation of substrates by the proteasome, however, also occurs. The number of documented proteasome-dependent, ubiquitin-independent degradation events remains relatively small but continues to grow. Proteins involved in oncogenesis and tumor suppression make up the majority of the known cases for this type of protein destruction. Provocatively, viruses with confirmed or suspected oncogenic properties are also prominent participants in the pantheon of ubiquitin-independent proteasomal degradation events. In this review, we identify and describe examples of proteasome-dependent, ubiquitin-independent protein degradation that occur during tumor virus infections, speculate why this type of protein destruction may be preferred during oncogenesis, and argue that this uncommon type of protein turnover represents a prime target for antiviral and anticancer therapeutics.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664948      PMCID: PMC3193896          DOI: 10.1016/j.bbcan.2011.05.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  163 in total

1.  A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.

Authors:  M Koegl; T Hoppe; S Schlenker; H D Ulrich; T U Mayer; S Jentsch
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

2.  The base of the proteasome regulatory particle exhibits chaperone-like activity.

Authors:  B C Braun; M Glickman; R Kraft; B Dahlmann; P M Kloetzel; D Finley; M Schmidt
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

3.  Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication.

Authors:  Stacy R Cantrell; Wade A Bresnahan
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 4.  Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.

Authors:  Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

5.  Murine cytomegalovirus US22 protein pM140 protects its binding partner, pM141, from proteasome-dependent but ubiquitin-independent degradation.

Authors:  Lisa L Bolin; Laura K Hanson; Jacquelyn S Slater; Julie A Kerry; Ann E Campbell
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

Review 6.  Tegument proteins of human cytomegalovirus.

Authors:  Robert F Kalejta
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

7.  Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability.

Authors:  Jennifer Blickwedehl; Manjula Agarwal; Changhyun Seong; Raj K Pandita; Thomas Melendy; Patrick Sung; Tej K Pandita; Naveen Bangia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-09       Impact factor: 11.205

Review 8.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 9.  Human retroviruses after 20 years: a perspective from the past and prospects for their future control.

Authors:  Robert C Gallo
Journal:  Immunol Rev       Date:  2002-07       Impact factor: 12.988

Review 10.  The ubiquitin system, disease, and drug discovery.

Authors:  Matthew D Petroski
Journal:  BMC Biochem       Date:  2008-10-21       Impact factor: 4.059

View more
  25 in total

1.  BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Authors:  Song Hee Lee; Robert F Kalejta; Julie Kerry; Oliver John Semmes; Christine M O'Connor; Zia Khan; Benjamin A Garcia; Thomas Shenk; Eain Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

2.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

3.  Roles of the two distinct proteasome pathways in hepatitis C virus infection.

Authors:  Ikuo Shoji
Journal:  World J Virol       Date:  2012-04-12

4.  The Proteasome Subunit Rpn8 Interacts with the Small Nucleolar RNA Protein (snoRNP) Assembly Protein Pih1 and Mediates Its Ubiquitin-independent Degradation in Saccharomyces cerevisiae.

Authors:  Alexandr Paci; Peter X H Liu; Lingjie Zhang; Rongmin Zhao
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

5.  Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.

Authors:  Marni S Crow; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2017-01-11       Impact factor: 5.911

6.  The carboxyl-terminal tail of Noxa protein regulates the stability of Noxa and Mcl-1.

Authors:  Xiaming Pang; Jingjing Zhang; Hernando Lopez; Yushu Wang; Wenyang Li; Katelyn L O'Neill; Jacquelynn J D Evans; Nicholas M George; Jianhong Long; Yi Chen; Xu Luo
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

7.  Repurposing Protein Degradation for Optogenetic Modulation of Protein Activities.

Authors:  Payel Mondal; Vishnu V Krishnamurthy; Savanna R Sharum; Neeka Haack; Huiwen Zhou; Jennifer Cheng; Jing Yang; Kai Zhang
Journal:  ACS Synth Biol       Date:  2019-10-21       Impact factor: 5.110

8.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

9.  Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.

Authors:  Varsha Rao; Bin Guan; Laura N Mutton; Charles J Bieberich
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

10.  Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle.

Authors:  Laura L Winkler; Jiwon Hwang; Robert F Kalejta
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.